Table 1 Clinical and demographic characteristics of patients and low-risk subjects.
Patients (n = 162) | Low-risk subjects (n = 212) | p value | |
|---|---|---|---|
Age (y), median (IQR) | 59 (39–70) | 20 (19–21) | p < 0.001* |
Male, n (%) | 129 (79.6%) | 105 (49.5%) | p < 0.001** |
Smear results (n) | positive (138) | NA | NA |
negative (24) | |||
Type of TB (n) | Pulmonary TB (162) | NA | NA |
Tuberculosis pleurisy (5) | |||
Tracheobronchial TB (4) | |||
Miliary TB (2) | |||
Laryngeal TB (2) | |||
Concomitant Drugs (n) | Anticonvulsant (3) | NA | NA |
Corticosteroid (5) | |||
Immunosuppressant and Corticosteroid (1) | |||
Corticosteroid and Cancer Chemotherapy (1) | |||
Monoclonal Antibody (0) | |||
History of BCG vaccine (n) | Unknown | yes (187) | NA |
uncertain (25) |
